Emergent says it has disposed of spoilt COVID-19 vaccine batch
(Reuters) – Johnson & Johnson’s manufacturing partner Emergent BioSolutions said on Thursday that it had disposed of the single batch of COVID-19 drug substance that did not meet specifications.
J&J on Wednesday said it had found a problem with a batch of the drug substance for its COVID-19 vaccine being produced at Emergent’s site in Baltimore, Maryland.
FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson/File Photo
“Discarding a batch of bulk drug substance, while disappointing, does occasionally happen during vaccine manufacturing, which is a complex and multi-step biological process”, Emergent said.
Reporting by Dania Nadeem in Bengaluru; Editing by Anil D’Silva
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
